Table 2 Unique indicators identified (n = 132)
Domain | Indicator (Sets it Appears In) [italics = appears in multiple sets] | Definition (Sets) | Type | Data Source | Overlap with Priority Indicators | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Facilities | Service Providers | Affected Population | Program Records | Not Specified | SDG | GS | Core WHO | ||||
ARH | Condom use among young people (b) | Percentage of sexually active young people who reported using a condom at last intercourse | Outcome | âś“ | |||||||
ARH | Incidence of STDs in young people (b) | Number of reported cases of STDs among young people by the specified time period per 1000 young people | Impact | âś“ | |||||||
ARH | Proportion of births among those under 18 years (b) | Percentage of all live births which were deliveries among women under 18 years of age | Impact | ✓ | ✓ | ✓ | ✓ | ||||
ARH | Proportion of STIs among those under 18 years (b, d) | Percentage of total number of STIs diagnosed which were diagnosed among those under 18 years of age | Impact | ✓ | |||||||
CAC | Abortion services performed with appropriate technology (b) | Percentage of abortion services performed in a given period which are performed with appropriate technology (vacuum aspiration or medical methods) | Output | âś“ | |||||||
CAC | Awareness of legal indications for termination of pregnancy (b) | Percentage of providers involved in abortion services who are aware of the legal indications for termination of pregnancy | Output | âś“ | |||||||
CAC | Coverage of induced abortion (b) | Percentage of all women receiving abortion services in a given facility during a given period who receive induced procedures | Outcome | âś“ | |||||||
CAC | Coverage of post-abortion contraception (b) | Percentage of all women receiving abortion services in a given facility during a given period who receive modern contraceptive methods before leaving the facility | Outcome | âś“ | |||||||
FP | Barriers to family planning (e) | Percentage of women not currently using a family planning method who report at least one barrier to family planning (except for fertility-related reasons) | Output | âś“ | |||||||
FP | Difficulty accessing contraception after the disaster (c) | Proportion of PP women who have had difficulty accessing their contraceptive method since the disaster | Output | âś“ | |||||||
FP | Community knowledge concerning family planning (b) | Percentage of all sexually active persons targeted for family planning messages who are able to cite major messages about family planning | Output | âś“ | |||||||
FP | Ever heard of modern family planning methods (e) | Percentage of women of reproductive age who have ever heard of at least one modern family planning method | Output | âś“ | |||||||
FP | Contraceptive supply (b) | Percentage of service delivery points which maintain a minimum of 3 months’ supply of combined oral contraceptive pills, progestin-only pills, and injectables | Process | ✓ | |||||||
FP | Couple years protection (d) | Duration of contraceptive protection provided by all contraceptives sold or distributed free of charge to clients per 1-year period | Output | âś“ | |||||||
FP | Coverage of FP counselling (b) | Percentage of clients attending FP services who are offered FP counselling in addition to receiving a method of contraception | Output | âś“ | |||||||
FP | Unmet need for family planning (e) | Percentage of all women of reproductive age who are currently not using a family planning method and are at risk for pregnancy (not using a method, not currently pregnant or postpartum, fecund, sexually active in the last 30 days, and do not want a baby in the immediate future) | Outcome | ✓ | |||||||
FP | Contraceptive prevalence (b, d, c) | Percentage of women 15–49 years of age who are using (or whose partner is using) a contraceptive method (b, d); Proportion of PP women who are currently practicing family planning with their partner, including natural family planning methods (c) | Outcome | ✓ | ✓ | ✓ | |||||
FP | Modern contraceptive prevalence (e) | Percentage of all women of reproductive age who are using any modern family planning method | Outcome | âś“ | âś“ | ||||||
FP | Use of family planning before disaster (c) | Proportion of PP women who were using a contraceptive method just before the disaster | Outcome | âś“ | |||||||
FP | Ever used modern family planning methods (e) | Percentage of women of reproductive age who have ever used at least one modern family planning method | Outcome | âś“ | |||||||
FP | Future intent to use a method in the next 12 months (e) | Percentage of women not currently using a family planning method who intend to use a family planning method in the next 12 months | Impact | ✓ | |||||||
GBV | Availability of clinical management of rape survivors (a, h, f) | Percentage of health facilities offering clinical management of rape survivors, including EC, PEP and presumptive STI treatment (a,h); Number of functional health facilities with clinical management of rape survivors in a defined administrative or health area at a certain time point (h); Not specified (f) | Output | âś“ | âś“ | ||||||
GBV | Percentage of health workers trained on clinical management of rape (h) | Percentage of all health workers which have been trained on Clinical Management of Rape | Output | âś“ | |||||||
GBV | Proportion of community-based workers trained in psychosocial support for GBV survivors (h) | Percentage of all community workers that have been trained in GBV psychosocial support | Output | âś“ | |||||||
GBV | Favorable to the continuation of FGC (e) | Percentage of women who have ever heard of FGC who think the practice should continue | Outcome | âś“ | |||||||
GBV | Future intent of FGC (e) | Percentage of women who have at least one daughter and have heard of FGC who intend to have youngest daughter’s genitals cut in the future | Outcome | ✓ | |||||||
GBV | Prevalence of female genital cutting (e) | Percentage of women of reproductive age who have ever had their genitals cut | Outcome | âś“ | âś“ | âś“ | |||||
GBV | Prevalence of female genital cutting among youngest daughter that occurred in current setting (e) | Percentage of women who have at least one daughter and have heard of FGC whose youngest daughter ever had their genitals cut and the cutting was done in their current location | Outcome | âś“ | |||||||
GBV | Number of reported rape cases (a, d) | Number of rape cases reported to health facilities within a specific time period (time period for reporting to be set locally) (a); Number of rape cases reported per 10,000 population per year (d) | Impact | âś“ | |||||||
GBV | Number of reported sexual violence cases (b, h) | Number of cases of sexual violence reported to health services per month per 10,000 population | Impact | âś“ | |||||||
GBV | Communities indicating there is a risk of physical or sexual violence (h) | Percentage of all communities which indicate that there is a risk of physical or sexual violence | Outcome | âś“ | |||||||
GBV | Intimate partner violence (IPV) ever (e) | Percentage of ever-partnered women who have ever experienced IPV by a current or previous partner | Impact | âś“ | |||||||
GBV | IPV in past year (e) | Percentage of women partnered in the past 12 months who have experienced IPV in the past 12 months | Impact | ✓ | ✓ | ✓ | ✓ | ||||
GBV | Outsider physical violence during conflict (e) | Percentage of women of reproductive age who have experienced physical violence by someone outside of their family during the conflict | Impact | âś“ | |||||||
GBV | Outsider physical violence post-conflict (e) | Percentage of women of reproductive age who have experienced physical violence by someone outside of their family post-conflict | Impact | âś“ | |||||||
GBV | Outsider sexual violence during conflict (e) | Percentage of women of reproductive age who have experienced sexual violence by someone outside of their family during the conflict | Impact | âś“ | |||||||
GBV | Outsider sexual violence post-conflict (e) | Percentage of women of reproductive age who have experience sexual violence by someone outside of their family post-conflict | Impact | âś“ | |||||||
GBV | Physical intimate partner violence since disaster (c) | Percentage of pregnant women reporting physical violence by husband or partner since the disaster | Impact | âś“ | |||||||
GBV | Physical violence by family members in past year (e) | Percentage of women of reproductive age who have experienced physical violence by family members in the past year | Impact | âś“ | |||||||
GBV | Physical violence by persons other than intimate partners since disaster (c) | Percentage of pregnant women reporting physical violence by person other than husband or partner since the disaster | Impact | âś“ | |||||||
GBV | Sexual violence by anyone, including intimate partners since disaster (c) | Percentage of pregnant women reporting sexual violence by anyone including husband or partner since the disaster | Impact | âś“ | |||||||
GBV | Current needs for services for family violence (c) | Percentage of pregnant women reporting current need for services to reduce violence in family | Outcome | âś“ | |||||||
GBV | Perceived effect of violence on physical or emotional health (c) | Percentage of pregnant women reporting perceived effects of the violence on physical or emotional health | Impact | âś“ | |||||||
GBV | Sought treatment for effects of violence (c) | Percentage of pregnant women who have experienced violence since the disaster and sought treatment from a doctor, counsellor, or any other medical care provider for resulting physical and/or emotional problems | Impact | âś“ | |||||||
GBV | Humanitarian organizations and service providers with codes of conduct for own staff (h) | Percentage of humanitarian organizations and service providers that have in place codes of conduct on prevention of sexual exploitation and abuse by own staff | Output | âś“ | |||||||
GBV | Humanitarian organizations and service providers with community-based feedback and complaint mechanisms (h) | Percentage of humanitarian organizations and service providers that have in place community-based feedback and complaint mechanisms | Output | âś“ | |||||||
GBV | Reporting IPV (e) | Percentage of women who have ever experienced IPV who told an authority (doctor/provider, police, military, NGO worker) about any incidence of IPV | Impact | âś“ | |||||||
GBV | Reporting outsider violence (e) | Percentage of women who experienced outsider violence during and post-conflict who told an authority (doctor/provider, police, military, NGO worker) about any incident of outsider violence | Impact | âś“ | |||||||
GBV | Timing of EC provision (b, d, h) | Percentage of all rape cases reported within 120 h where survivors receive ECP within 120 h of incident (b, d); Percentage of female rape survivors who receive ECP within 120 h of the incident (h) | Outcome | ✓ | |||||||
GBV | Timing of PEP provision (b, d, h) | Percentage of all rape cases reported within 72 h where survivors receive PEP within 72 h of incident (b, d); Percentage of reported rape cases where survivor receives PEP for HIV within 72 h of incident (h) | Outcome | ✓ | ✓ | ||||||
GBV | Timing of STI prophylaxis (b, d) | Percentage of all rape cases reported in which survivors receive presumptive STI treatment within 2 weeks of an incident occurring (b); Percentage of all rape cases reported within 2 weeks where survivors receive presumptive STI treatment within 2 weeks (d) | Outcome | ✓ | |||||||
HIV | Eligibility for ART (d) | Number of people enrolled in HIV care and eligible for ART but not started on ART by end of period in one camp over a one-year time period | Impact | âś“ | |||||||
HIV | Number on ART (d) | Number of people started on ART in one camp over a one-month time period | Outcome | âś“ | âś“ | âś“ | |||||
HIV | Coverage of HIV rapid tests for safe blood transfusion (a) | Percentage of health service delivery points with sufficient HIV rapid tests to screen blood for transfusion | Output | âś“ | |||||||
HIV | Quality of blood donation screening (b, d, f) | Percentage of donated blood units screened for HIV in a quality assured manner (b, d); Not specified (f) | Outcome | âś“ | |||||||
HIV | Condom distribution rate (d, a) | Number of condoms distributed per person per month (d); Number of male condoms distributed per total population per month (a) | Output | âś“ | |||||||
HIV | Condom use (b, e) | Percentage of sexually active people reporting condom use at last intercourse (b); Percentage of women who had sex with a casual partner in the last 12 months who did not use a condom at last intercourse € | Outcome | ✓ | ✓ | ||||||
HIV | Accepting attitudes of people living with HIV/AIDS (e) | Percentage of women who have ever heard of HIV/AIDS who indicate that they: do not believe HIV positive status of family member should be kept secret, are willing to care for HIV positive family member in home, believe HIV positive teacher should be allowed to continue teaching, and would buy fresh vegetables from an HIV positive person | Outcome | âś“ | |||||||
HIV | Comprehensive correct knowledge of HIV/AIDS (e) | Percentage of women of reproductive age who indicate that they: know condoms prevent HIV, know sex with only 1 faithful uninfected partner prevents HIV, do not think mosquitoes transmit HIV, do not think sharing food transmits HIV, and know a healthy-looking person can have HIV | Outcome | âś“ | |||||||
HIV | Comprehensive correct knowledge of mother-to-child transmission of HIV/AIDS (e) | Percentage of women of reproductive age who know that HIV/AIDS can be transmitted from mother to child during pregnancy or delivery, and through breastfeeding | Outcome | âś“ | |||||||
HIV | Perceived risk of getting HIV/AIDS (e) | Percentage of women who have ever heard of HIV/AIDS who believe they are at moderate to high risk of getting HIV/AIDS among women who have ever heard of HIV/AIDS | Outcome | âś“ | |||||||
HIV | Enrolled in HIV care who had TB status assessed (d) | Percentage of people enrolled in HIV care and seen for care who had TB status assessed and recorded during their last visit | Output | âś“ | |||||||
HIV | Targeting of people most at risk of exposure to HIV with a HIV prevention programme (f) | Not Specified | Output | âś“ | |||||||
HIV | Timing of PEP (f, g) | Percentage of individuals potentially exposed to HIV that receive PEP within 72 h of incident | Outcome | ✓ | |||||||
HIV | Infant HIV positive rate (d) | Percentage of all deliveries to HIV-positive mothers where the infant tested positive at 18 months of age | Impact | ✓ | |||||||
HIV | PMTCT ARV coverage (infant) (d) | Percentage of all deliveries to HIV-positive mothers where the infant swallowed ARV within 72 h of delivery | Outcome | ✓ | |||||||
HIV | PMTCT ARV coverage (mother) (d) | Percentage of all deliveries to HIV-positive mothers where the mother swallowed ARV during labour/delivery | Outcome | âś“ | âś“ | ||||||
HIV | PMTCT ARV coverage (mother-infant pair) (b, d) | Percentage of all deliveries to HIV-positive mothers where the mother-infant pair swallowed ARV according to protocol | Outcome | âś“ | âś“ | ||||||
HIV | PMTCT ARV use for treatment (d) | Percentage of all eligible HIV-infected pregnant women who received anti-retroviral as treatment | Outcome | âś“ | |||||||
HIV | Receipt of ARV drugs for PMTCT by pregnant women known to be HIV positive (f) | Not Specified | Outcome | âś“ | âś“ | ||||||
HIV | PMTCT Co-trimoxazole prophylaxis (infant) (d) | Percentage of all deliveries to HIV-positive mothers where the infant was started on co-trimoxazole prophylaxis | Outcome | âś“ | |||||||
HIV | PMTCT Co-trimoxazole prophylaxis (mother) (d) | Percentage of all deliveries to HIV-positive mothers where the mother was started on co-trimoxazole prophylaxis | Outcome | âś“ | |||||||
HIV | PMTCT pre-test counselling coverage (b, d) | Percentage of first ANC visit clients who were pre-test counselled | Output | âś“ | |||||||
HIV | PMTCT Exclusive breastfeeding rate (d) | Percentage of all deliveries to HIV-positive mothers where the mother plans to exclusively breastfeed after delivery | Outcome | âś“ | |||||||
HIV | PMTCT Family planning acceptance rate (d) | Percentage of all deliveries to HIV-positive mothers where the mother accepted a modern method of family planning after delivery | Outcome | âś“ | |||||||
HIV | PMTCT HIV prevalence rate (d) | Percentage of all first antenatal care visits with HIV testing where the patient tested positive for HIV | Impact | âś“ | |||||||
HIV | PMTCT Home-based counselling (d) | Percentage of all deliveries to HIV-positive mothers where the mother received at least one home-based counselling visit after delivery | Output | âś“ | |||||||
HIV | PMTCT Post-test counselling and result (partners) (d) | Percentage of all antenatal care partners, who were pre-test counselled and HIV tested, who received post-test results and counselling | Output | âś“ | |||||||
HIV | PMTCT post-test counselling and result (b, d) | Percentage of first ANC visit clients tested for HIV who receive post-test result and counselling | Output | âś“ | |||||||
HIV | Proportional PMTCT service use by Nationals (d) | Percentage of all PMTCT clients pre-test counselled who were Nationals | Outcome | âś“ | |||||||
HIV | Coverage of supplies for standard precautions (g, a) | Percentage of health service delivery points with adequate supplies to carry out standard precautions | Output | âś“ | |||||||
HIV | Proportional VCT service use by nationals (d) | Percentage of all VCT clients pre-test counselled who are Nationals | Outcome | âś“ | |||||||
HIV | Received HIV test results in the last 12 months (e) | Percentage of women who were tested for HIV in the last 12 months who received their HIV test results | Output | ✓ | |||||||
HIV | VCT post-test counselling and result (b, d) | Percentage of VCT clients tested for HIV who received post-test result and counselling | Output | âś“ | |||||||
HIV | Would have an HIV test in the future (e) | Percentage of women who have ever heard of HIV/AIDS who would go for an HIV test in the future | Outcome | âś“ | |||||||
MH | Complete ANC coverage (b, d, e) | Percentage of total number of live births in which the mother made at least 4 ANC visits during the antenatal period at the time of delivery (b, d); Percentage of all women whose most recent pregnancy ended in a live birth or stillbirth in the last two years who received at least 3 antenatal care visits by a trained provider (e) | Outcome | âś“ | âś“ | âś“ | âś“ | ||||
MH | Coverage of syphilis screening (b, d) | Percentage of total number of live births where the mother had been screened for syphilis during the antenatal period at the time of delivery | Outcome | âś“ | âś“ | ||||||
MH | Tetanus vaccination coverage (b, d) | Percentage of total number of live births where the mother had received 2 doses of tetanus toxoid vaccine (or were fully vaccinated) during the antenatal period at the time of delivery | Outcome | âś“ | |||||||
MH | Timing of first antenatal visit (d) | Percentage of first-time antenatal visits that were made in the first trimester | Outcome | âś“ | |||||||
MH | Coverage of intermittent presumptive treatment for malaria (d) | Percentage of all live births where the mother had received two doses of fansidar prophylaxis during the antenatal period at the time of delivery | Outcome | âś“ | âś“ | ||||||
MH | Coverage of long-lasting insecticidal nets (g) | Number of pregnant and lactating women and children under 5 sleeping nightly under net | Outcome | âś“ | |||||||
MH | Percentage of caesarean section (b, d, f, h) | Percentage of live births which are delivered via Caesarean sections | Outcome | âś“ | |||||||
MH | Coverage of clean delivery kits (a, g, f) | Number of clean delivery kits distributed per hundred pregnant women per month (a, g); Women in third trimester of pregnancy who have received clean delivery kits (f) | Output | âś“ | |||||||
MH | Delivery assisted by a skilled attendant (b, d, h, e) | Percentage of all deliveries which are attended by a trained health worker (b); Percentage of all live births attended by skilled birth attendants (d, h); Percentage of all women whose most recent pregnancy ended in a live birth or stillbirth in the last two years whose delivery was attended by a trained health care provider at a health facility (e) | Outcome | âś“ | âś“ | âś“ | âś“ | âś“ | |||
MH | BEmOC services availability (f, h) | Number of functional health facilities with BEmOC per 500,000 population | Output | âś“ | âś“ | ||||||
MH | CEmOC services availability (f, h) | Number of functional health facilities with CEmOC per 500,000 population | Output | âś“ | âś“ | ||||||
MH | EmOC needs met (b) | Percentage of all deliveries with major obstetric complications which are treated at an EmOC facility | Outcome | âś“ | |||||||
MH | EmOC services availability (b) | Number of health facilities with basic and/or comprehensive obstetric care per 500,000 population by administrative unit | Output | âś“ | âś“ | ||||||
MH | EmOC services utilization (b, d) | Percentage of all deliveries which occur in an EmOC center | Outcome | âś“ | |||||||
MH | Health problems during pregnancy (c) | Percentage of women reporting health problems that require ongoing care. This includes diabetes, vaginal bleeding, urinary tract infections, sever nausea and vomiting, hypertensive disorders, heart problems, and any other identified by the interviewee. | Outcome | âś“ | |||||||
MH | Prevalence of anaemia (d) | Percentage of all antenatal mothers tested for anaemia with severe and moderate anaemia | Impact | âś“ | |||||||
MH | Prevalence of syphilis (d) | Percentage of antenatal mothers tested for syphilis that tested positive on Rapid Plasma Reagent testing | Impact | âś“ | |||||||
MH | Help-seeking behavior for postpartum complications (e) | Percentage of all women who reported postpartum complications after their most recent pregnancy that ended in a live birth or stillbirth in the last two years who sought help at a health facility | Outcome | âś“ | |||||||
MH | Help-seeking behavior for pregnancy complications (e) | Percentage of all women who reported complications before labor or delivery with their most recent pregnancy that ended in a live birth or stillbirth in the last two years who sought help at a health facility | Outcome | âś“ | |||||||
MH | Knowledge of danger signs of pregnancy complications (e) | Percentage of all women of reproductive age who know at least two danger signs of pregnancy complications | Output | âś“ | |||||||
MH | Pregnant women aware of where to go for labour and delivery (g) | Percentage of women who receive birth kits who receive counselling on the need for skilled birth attendance for delivery and know where to go | Output | âś“ | |||||||
MH | Proportion of low birth weight (c, b, d) | Proportion of postpartum women who reported their infants weighed less than 2500 g at birth (c); Percentage of total number of live births (with birth weight recorded) where the infant weighs less than 2500 g (b, d) | Impact | ✓ | ✓ | ✓ | |||||
MH | Preterm birth (c) | Proportion of PP women who reported they delivered a live singleton baby at least three weeks before their due date | Impact | âś“ | |||||||
MH | Direct obstetric case fatality rate (b) | Percentage of all women seen for a direct obstetric complication at an EmOC facility who die of a direct obstetric complication | Impact | âś“ | |||||||
MH | Investigation of maternal deaths (b, d) | Percentage of total number of reported maternal deaths which are investigated | Output | âś“ | âś“ | ||||||
MH | Maternal mortality ratio (d) | Number of pregnancy-related deaths per 100,000 live births | Impact | âś“ | âś“ | âś“ | âś“ | ||||
MH | Number of maternal deaths reported (d) | Number of reported maternal deaths | Output | âś“ | |||||||
MH | Abortion ratio (d) | Number of abortions (defined as spontaneous miscarriage before 22 weeks gestation) per 1000 live births | Impact | ✓ | |||||||
MH | Neonatal mortality rate (b, d) | Number of live born infants who die at less than 28 days of age per 1000 live births in the specified period | Impact | ✓ | ✓ | ✓ | ✓ | ||||
MH | Stillbirth rate (b, d) | Number of still births per 1000 births (still and live) per month | Impact | âś“ | âś“ | âś“ | |||||
MH | Access to postpartum care (c) | Not specified | Output | âś“ | |||||||
MH | Postnatal care coverage (b, d, e) | Percentage of all live births where the mother received postnatal care 3 times within 6 weeks of delivery (b, d); Percentage of all women whose most recent pregnancy ended in a live birth or stillbirth in the last two years who received at least 1 postpartum care visit within six weeks after delivery (e) | Outcome | ✓ | ✓ | ✓ | ✓ | ||||
MH | Disaster related difficulty when accessing postpartum care (c) | Percentage of women who experienced difficulty obtaining a postpartum check-up because of the disaster | Outcome | âś“ | |||||||
MH | Crude birth rate (d) | Number of live births per 1000 total population | Impact | âś“ | |||||||
MH | Currently pregnant (e) | Percentage of all women of reproductive age who are currently pregnant | Impact | âś“ | |||||||
MH | Pregnancies in last two years (e) | Percentage of all women of reproductive age who have had one or more pregnancies in the last two years | Impact | âś“ | |||||||
STI | Incidence of genital ulcer disease (b, d) | Number of cases of genital ulcer disease per 1000 population per month | Impact | âś“ | âś“ | ||||||
STI | Incidence of male urethral discharge (b, d) | Number of cases of male urethral discharge reported per 1000 population per month | Impact | âś“ | âś“ | ||||||
STI | Selected STI-associated symptoms in the past 12 months (e) | Percentage of women of reproductive age who have had unusual genital discharge and/or genital ulcers or sores in the last 12 months | Impact | ✓ | ✓ | ||||||
STI | Syphilis prevalence rate (OPD) (d) | Percentage of all STI patients tested who tested positive for syphilis using a pre-qualified syphilis test | Impact | âś“ | |||||||
STI | Help-seeking behaviors for treating selected STI-associated symptoms (e) | Percentage of women who had unusual genital discharge and/or genital ulcers or sores in the last 12 months who went to a health facility for treatment | Outcome | ✓ | |||||||
STI | Knowledge of selected STI-associated symptoms (e) | Percentage of women of reproductive age who know at least one of three selected STI-associated symptoms | Output | âś“ | |||||||
STI | Partner tracing (d) | Percentage of positive syphilis cases where contacts were tested | Output | âś“ | |||||||
STI | Access to STI services since disaster (c) | Not Specified | Output | âś“ | |||||||
STI | Primary healthcare facilities with antimicrobials to provide syndromic management to patients presenting with symptoms of an STI (f) | Not Specified | Output | âś“ | |||||||
STI | STI/RTI case management (b) | Percentage of total number of patients with STI/RTI accessing services that are assessed, treated and counselled according to protocol | Outcome | âś“ | |||||||
STI | STI/RTI management skills of service providers (b) | Percentage of service providers trained (or retrained) to manage STI/RTI cases according to protocol | Process | âś“ | |||||||